Legal Representation
Attorney
Tracy-Gene G. Durkin
Application History
50 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 14, 2018 | INNP | P | PARTIAL INVALIDATION PROCESSED BY THE IB | Loading... |
| Oct 1, 2018 | INPC | P | INVALIDATION PROCESSED | Loading... |
| Oct 1, 2018 | INPS | P | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | Loading... |
| Sep 27, 2018 | INPR | P | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | Loading... |
| Jan 27, 2018 | 71AG | O | REGISTERED-SEC.71 ACCEPTED | Loading... |
| Jan 27, 2018 | PRAN | O | POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED | Loading... |
| Jan 27, 2018 | NA71 | E | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | Loading... |
| Jan 25, 2018 | ES75 | I | TEAS SECTION 71 & 15 RECEIVED | Loading... |
| Jan 25, 2018 | 71AF | I | REGISTERED-SEC.71 FILED | Loading... |
| Aug 31, 2017 | CHLD | M | CHANGE OF OWNER RECEIVED FROM IB | Loading... |
| Apr 29, 2017 | REM4 | E | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | Loading... |
| Nov 24, 2016 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Oct 1, 2016 | RNWL | P | INTERNATIONAL REGISTRATION RENEWED | Loading... |
| Jul 10, 2013 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Jul 10, 2013 | 715F | I | REGISTERED - SEC. 71 & SEC. 15 FILED | Loading... |
| Jul 10, 2013 | C75A | O | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | Loading... |
| Jul 10, 2013 | NA75 | E | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | Loading... |
| Jul 5, 2013 | ES75 | I | TEAS SECTION 71 & 15 RECEIVED | Loading... |
| Dec 22, 2012 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Aug 18, 2008 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Aug 18, 2008 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Jul 31, 2008 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Jul 29, 2008 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Apr 29, 2008 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Feb 12, 2008 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 23, 2008 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Jan 7, 2008 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jan 7, 2008 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Nov 19, 2007 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 17, 2007 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Oct 17, 2007 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 17, 2007 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 23, 2007 | CPRA | R | PRIORITY ACTION WRITTEN | Loading... |
| Aug 23, 2007 | CPRA | O | PRIORITY ACTION MAILED | Loading... |
| Aug 16, 2007 | CNEA | O | EXAMINERS AMENDMENT MAILED | Loading... |
| Aug 15, 2007 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Aug 15, 2007 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Aug 1, 2007 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Aug 1, 2007 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 1, 2007 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 1, 2007 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Mar 2, 2007 | ATRV | O | ATTORNEY REVIEW COMPLETED | Loading... |
| Feb 23, 2007 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Feb 12, 2007 | CREV | I | CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED | Loading... |
| Feb 8, 2007 | CRCV | M | CORRECTION TRANSACTION RECEIVED FROM IB | Loading... |
| Feb 1, 2007 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Feb 1, 2007 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Feb 1, 2007 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Jan 31, 2007 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jan 24, 2007 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 001
Reagents for scientific use in biological processing; biological preparations for scientific use in cell cultures; cultures of cell media for scientific use; media in the nature of buffer and standard solutions used in analytical chemistry for cell culture for use in scientific laboratories; media in the nature of buffer for scientific use; [ diagnostic preparations for scientific use, namely, antibodies; ELISA test kits, namely, biological reagents for use in enzyme linked immunosorbent assays for the biochemical detection of substances for scientific use; products, namely, kits containing antibodies for scientific use; ] tissue culture reagents for scientific and medical research use; cell culture reagents for scientific and medical research use; [ biological test kits composed of buffer and standard solutions used in analytical chemistry, vectors, cells and reagents for scientific and medical research use; ] cell culture media in the nature of buffer and standard solutions for scientific use
First Use Anywhere:
0
First Use in Commerce:
0
Class 005
[ Biological reagents for medical use in embryology; biological reagents for medical purposes in the field of molecular biology; reagents for use in biological processing for medical purposes; reagents for use in biological processing for veterinary purposes; ] agents in the nature of hormones, cytokines, antigens and immunoglobulins for activating cellular functions [ ; biological preparations for use in cell cultures for medical purposes; antitoxic sera; antitoxic sera for in-vivo use for medical purposes; antibodies for the treatment of disease; antibodies for immunodiagnostic medical purposes; antibodies for immunoprophylatic medical purposes; antibodies for immunotherapeutic medical purposes; antibodies for in-vivo use in detecting diseases in livestock; immunological antibodies for medical use; ELISA test kits, namely, biological reagents for use in enzyme linked immunosorbent assays for the biochemical detection of substances for medical and medical laboratory use; tissue culture reagents for medical and medical laboratory use; cell culture media in the nature of buffer and standard solutions for medical and medical laboratory use ]
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Pseudo Mark
NEURAL DIFFERENTIATION
Classification
International Classes
001
005